<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39418135</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1753-4666</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Therapeutic advances in respiratory disease</Title><ISOAbbreviation>Ther Adv Respir Dis</ISOAbbreviation></Journal><ArticleTitle>Optimizing the safety and efficacy of the awake venovenous extracorporeal membrane oxygenation in patients with COVID-19-related ARDS.</ArticleTitle><Pagination><StartPage>17534666241282590</StartPage><MedlinePgn>17534666241282590</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17534666241282590</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/17534666241282590</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Maintaining the patient awake and not intubated during the venovenous extracorporeal membrane oxygenation (VV ECMO) reduces the risk of ventilation-induced lung injury in patients with ARDS. Currently, there is a lack of data on outcomes and complications associated with the awake ECMO approach.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">To evaluate outcomes and the occurrence of complications of awake ECMO approach guided by local safety protocol comprising ultrasound-guided cannulation, argatroban-based anticoagulation, respiratory support, and routine sedation targeted to reduce respiratory effort and keeping nurse-to-patient ratio of 1:1.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">A single-center retrospective case series analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Consecutive patients with COVID-19-related acute respiratory distress syndrome (ARDS) (CARDS) treated by full awake VV ECMO approach from April 2019 to December 2023 were eligible.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our center treated 10 patients (mean age 54.7 ± 11.6 years) with CARDS with an awake ECMO approach. The reasons for awake ECMO included the presence of barotrauma in six patients, a team consensus to prefer awake ECMO instead of mechanical ventilation in three patients, and the patient's refusal to be intubated in one case. Before ECMO, patients were severely hypoxemic, with a mean value of Horowitz index of 48.9 ± 9.1 mmHg and a mean respiratory rate of 28.8 ± 7.3 breaths per minute on high-flow nasal cannula or noninvasive ventilation support. The mean duration of awake VV ECMO was 558.0 ± 173.6 h. Seven patients (70%) were successfully disconnected from ECMO and fully recovered. Intubation from respiratory causes was needed in three patients (30%), all of whom died eventually. In total, three episodes of delirium, two episodes of significant bleeding, one pneumothorax requiring chest tube insertion, and one oxygenator acute exchange occurred throughout the 5580 h of awake ECMO. No complications related to cannula displacement or malposition occurred.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The awake ECMO strategy guided by safety protocol appears to be a safe approach in conscious, severely hypoxemic, non-intubated patients with COVID-19-related ARDS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sklienka</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0330-5323</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital of Ostrava, 17. listopadu 1790, Ostrava 70800, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava 70300, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava70300, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burša</LastName><ForeName>Filip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frelich</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Máca</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vodička</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straková</LastName><ForeName>Hana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bílená</LastName><ForeName>Markéta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romanová</LastName><ForeName>Tereza</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomášková</LastName><ForeName>Hana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Respir Dis</MedlineTA><NlmUniqueID>101316317</NlmUniqueID><ISSNLinking>1753-4658</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY90U61Z3S</RegistryNumber><NameOfSubstance UI="C031942">argatroban</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010875">Pipecolic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014851" MajorTopicYN="Y">Wakefulness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018084" MajorTopicYN="N">Ultrasonography, Interventional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010875" MajorTopicYN="N">Pipecolic Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText><b>Enhancing the safety and effectiveness of extracorporeal membrane oxygenation (ECMO) therapy in awake, spontaneously breathing patients with the most severe form of COVID-19-related acute respiratory distress syndrome (ARDS)</b>Why Was the Study Done? Extracorporeal membrane oxygenation (ECMO) represents a life-saving therapeutic approach that ensures appropriate gas exchange in patients with the most severe form of respiratory failure – acute respiratory distress syndrome (ARDS). Typically, patients are connected to ECMO when already deeply sedated and mechanically ventilated. The awake ECMO approach (keeping the patient awake, not intubated, and breathing spontaneously during ECMO support) minimizes the risks associated with mechanical ventilation and provides several relevant physiological benefits. However, the awake ECMO approach is also associated with several significant risks, including delirium, bleeding, and cannula displacement. Published papers have reported relatively frequent complications and method failures. What Did the Researchers Do? To address safety concerns regarding the awake ECMO approach, we present a single-center retrospective analysis of ten COVID-19-related ARDS patients treated with the awake ECMO approach, guided by the local safety protocol. What Did the Researchers Find? The awake ECMO approach yielded success (i.e., the patient was not intubated for respiratory causes, was successfully disconnected from ECMO, and fully recovered in seven patients (70.0%), outperforming previously published efficacy ranges. Three patients were intubated due to the progression of respiratory failure and eventually died. The incidence of adverse events during the 5,580 hours of awake ECMO was considered low. No cannula displacement or malposition occurred despite routine active physiotherapy, including walking during ECMO treatment in three patients. What Do the Findings Mean? The general applicability of the study is limited by the low number of patients and the retrospective monocentric design. However, the presented data illustrate real-life clinical scenarios and could aid clinicians in managing severely hypoxemic but still conscious and cooperative patients.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">awake venovenous extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">bleeding</Keyword><Keyword MajorTopicYN="N">delirium</Keyword><Keyword MajorTopicYN="N">patient self-inflicted lung injury</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39418135</ArticleId><ArticleId IdType="pmc">PMC11489919</ArticleId><ArticleId IdType="doi">10.1177/17534666241282590</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kallet RH, Branson RD, Lipnick MS. Respiratory drive, dyspnea, and silent hypoxemia: a physiological review in the context of COVID-19. Respir Care 2020; 67: 1343–1360.</Citation><ArticleIdList><ArticleId IdType="pubmed">35501129</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruces P, Retamal J, Hurtado DE, et al.. A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection. Crit Care 2020; 24: 494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7416996</ArticleId><ArticleId IdType="pubmed">32778136</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli E, Mauri T, Beitler JR, et al.. Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions. Intensive Care Med 2020; 46: 606–618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224136</ArticleId><ArticleId IdType="pubmed">32016537</ArticleId></ArticleIdList></Reference><Reference><Citation>Busana M, Gasperetti A, Giosa L, et al.. Prevalence and outcome of silent hypoxemia in COVID-19. Minerva Anestesiol 2021; 87: 325–333.</Citation><ArticleIdList><ArticleId IdType="pubmed">33694360</ArticleId></ArticleIdList></Reference><Reference><Citation>Elabbadi A, Urbina T, Berti E, et al.. Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients. Crit Care 2022; 26: 350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9652578</ArticleId><ArticleId IdType="pubmed">36371306</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahsavarinia K, Rahvar G, Soleimanpour H, et al.. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in critically ill COVID-19 patients: a systematic review. Pak J Med Sci 2022; 38: 730–735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9002418</ArticleId><ArticleId IdType="pubmed">35480506</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo W, Kipkorir V, Marza AM, et al.. Prognosis of spontaneous pneumothorax/pneumomediastinum in coronavirus disease 2019: the CoBiF Score. J Clin Med 2022; 11: 7132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9739102</ArticleId><ArticleId IdType="pubmed">36498706</ArticleId></ArticleIdList></Reference><Reference><Citation>Langer T, Santini A, Bottino N, et al.. “Awake” extracorporeal membrane oxygenation (ECMO): pathophysiology, technical considerations, and clinical pioneering. Crit Care 2016; 20: 150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4928342</ArticleId><ArticleId IdType="pubmed">27357690</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Gu S, Li M, et al.. Awake extracorporeal membrane oxygenation for acute respiratory distress syndrome: which clinical issues should be taken into consideration. Front Med (Lausanne) 2021; 8: 682526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8282255</ArticleId><ArticleId IdType="pubmed">34277659</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotti S, Bottino N, Spinelli E. Spontaneous breathing during veno-venous extracorporeal membrane oxygenation. J Thorac Dis 2018; 10: S661–S669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911559</ArticleId><ArticleId IdType="pubmed">29732184</ArticleId></ArticleIdList></Reference><Reference><Citation>ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, et al.. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012; 307: 2526–2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Grissom CK, Moss M, et al.. NIH/NHLBI PETAL network collaborators. nonlinear imputation of Pao2/Fio2 From Spo2/Fio2 among patients with acute respiratory distress syndrome. Chest 2016; 150: 307–313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4980543</ArticleId><ArticleId IdType="pubmed">26836924</ArticleId></ArticleIdList></Reference><Reference><Citation>Assouline B, Combes A, Schmidt M. Setting and monitoring of mechanical ventilation during venovenous ECMO. Crit Care 2023; 27: 95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10027594</ArticleId><ArticleId IdType="pubmed">36941722</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonna JE, Abrams D, Brodie D, et al.. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO). ASAIO J 2021; 67(6): 601–610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315725</ArticleId><ArticleId IdType="pubmed">33965970</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al.. STROBE initiative. strengthnening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335: 806–808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeper MM, Wiesner O, Hadem J, et al.. Extracorporeal membrane oxygenation instead of invasive mechanical ventilation in patients with acute respiratory distress syndrome. Intensive Care Med 2013; 39: 2056–2057.</Citation><ArticleIdList><ArticleId IdType="pubmed">23921981</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Gu S, Li M, et al.. Spontaneous breathing in patients with severe acute respiratory distress syndrome receiving prolonged extracorporeal membrane oxygenation. BMC Pulm Med 2019; 19: 237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6902615</ArticleId><ArticleId IdType="pubmed">31818300</ArticleId></ArticleIdList></Reference><Reference><Citation>Assanangkornchai N, Slobod D, Qutob R, et al.. Awake venovenous extracorporeal membrane oxygenation for coronavirus disease 2019 acute respiratory failure. Crit Care Explor 2021; 3: e0489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8284710</ArticleId><ArticleId IdType="pubmed">34286281</ArticleId></ArticleIdList></Reference><Reference><Citation>Galante O, Hasidim A, Almog Y, et al.. Awake ECMO research team. Extracorporeal membrane oxygenation in non-intubated patients (Awake ECMO) with COVID-19 adult respiratory distress syndrome: the israeli experience. ASAIO J 2023; 69: e363–e367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10627399</ArticleId><ArticleId IdType="pubmed">37505201</ArticleId></ArticleIdList></Reference><Reference><Citation>Mang S, Reyher C, Mutlak H, et al.. AWECO-Study Group. Awake extracorporeal membrane oxygenation for COVID-19-induced acute respiratory distress syndrome. Am J Respir Crit Care Med 2022; 205: 847–851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9836215</ArticleId><ArticleId IdType="pubmed">35044896</ArticleId></ArticleIdList></Reference><Reference><Citation>Paternoster G, Bertini P, Belletti A, et al.. Venovenous extracorporeal membrane oxygenation in awake non-intubated patients with COVID-19 ARDS at high risk for barotrauma. J Cardiothorac Vasc Anesth 2022; 36: 2975–2982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926433</ArticleId><ArticleId IdType="pubmed">35537972</ArticleId></ArticleIdList></Reference><Reference><Citation>Paternoster G, Belmonte G, Scarano E, et al.. COVID-Macklin Study Group. Macklin effect on baseline chest CT scan accurately predicts barotrauma in COVID-19 patients. Respir Med 2022; 197: 106853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9020841</ArticleId><ArticleId IdType="pubmed">35512457</ArticleId></ArticleIdList></Reference><Reference><Citation>Zochios V, Brodie D, Shekar K, et al.. Invasive mechanical ventilation in patients with acute respiratory distress syndrome receiving extracorporeal support: a narrative review of strategies to mitigate lung injury. Anaesthesia 2022; 77: 1137–1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">35864561</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonkman AH, de Vries H, Heunks LMA. Physiology of the respiratory drive in ICU patients: implications for diagnosis and treatment. Crit Care 2020; 24: 104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092542</ArticleId><ArticleId IdType="pubmed">32204710</ArticleId></ArticleIdList></Reference><Reference><Citation>Öner Ö, Ergan B, Kizil AS, et al.. Investigation of high flow nasal cannula efficiency with electric impedance tomography based parameters in COVID-19 adults patients: a retrospective study. PeerJ 2023; 14: 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10351510</ArticleId><ArticleId IdType="pubmed">37465153</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri T, Alban L, Turrini C, et al.. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med 2017; 43: 1453–1463.</Citation><ArticleIdList><ArticleId IdType="pubmed">28762180</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile MC, Mauri T, Spinelli E, et al.. Nasal high flow higher than 60 L/min in patients with acute hypoxemic respiratory failure: a physiological study. Crit Care 2020; 24: 654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682052</ArticleId><ArticleId IdType="pubmed">33225971</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetrugno L, Castaldo N, Fantin A, et al.. Ventilatory associated barotrauma in COVID-19 patients: a multicenter observational case-control study (COVI-MIX-study). Pulmonology 2022; 24: 260–264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9684110</ArticleId><ArticleId IdType="pubmed">36669936</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin MJ. Why physiology is critical to the practice of medicine: a 40-year personal perspective. Clin Chest Med 2019; 40: 243–257.</Citation><ArticleIdList><ArticleId IdType="pubmed">31078207</ArticleId></ArticleIdList></Reference><Reference><Citation>Apigo M, Schechtman J, Dhliwayo N, et al.. Development of a work of breathing scale and monitoring need of intubation in COVID-19 pneumonia. Crit Care 2020; 24: 477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393620</ArticleId><ArticleId IdType="pubmed">32736637</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes LF, Bastidas Goyes A, Tuta Quintero EA, et al.. Validity of the ROX index in predicting invasive mechanical ventilation requirement in pneumonia. BMJ Open Respir Res 2022; 9: e001320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9476132</ArticleId><ArticleId IdType="pubmed">36104104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli R, Cortegiani A, Marchioni A, et al.. Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure. Crit Care 2022; 26: 70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943795</ArticleId><ArticleId IdType="pubmed">35331323</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli R, Busani S, Tabbì L, et al.. Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19: a Matched Control Study. Am J Respir Crit Care Med 2021; 204: 725–728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8521698</ArticleId><ArticleId IdType="pubmed">34214009</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Lin J, Wu T, et al.. Risk factors for delirium among hospitalized adults with COVID-19: a systematic review and meta-analysis of cohort studies. Int J Nurs Stud 2023; 148: 104602.</Citation><ArticleIdList><ArticleId IdType="pubmed">37801933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano H, Kamio T, Fukaguchi K, et al.. Analysis of adverse events related to extracorporeal membrane oxygenation from a nationwide database of patient-safety accidents in Japan. J Artif Organs 2023; 16: 1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9933024</ArticleId><ArticleId IdType="pubmed">36795227</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DH, Cho WH, Son J, et al.. Catastrophic mechanical complications of extracorporeal membrane oxygenation. ASAIO J 2021; 67(9): 1000–1005.</Citation><ArticleIdList><ArticleId IdType="pubmed">33528158</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway EM, Mackman N, Warren RQ, et al.. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022; 22: 639–649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez JI, Gosling AF, O’Gara B, et al.. Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis. Intensive Care Med 2022; 48: 213–224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9178906</ArticleId><ArticleId IdType="pubmed">34921625</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Zhang Y, Liu J, et al.. Thrombosis and bleeding in patients with COVID-19 requiring extracorporeal membrane oxygenation: a systematic review and meta-analysis. Res Pract Thromb Haemost 2023; 7: 100103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9993729</ArticleId><ArticleId IdType="pubmed">36999123</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>